Caffeoyl Hexapeptide-9: New Peptide Boosts Collagen and Fights UV Skin Damage

The cosmetics industry is witnessing a shift toward precision-engineered chemistry with the development of a novel peptide-caffeic acid conjugate, dubbed Caffeoyl hexapeptide-9 (CH-9). This hybrid molecule demonstrates enhanced stability, skin penetration, and clinical results in restoring skin firmness, offering a potential breakthrough in combating the effects of photoaging – skin damage caused by exposure to ultraviolet (UV) radiation. The research, a collaboration between Shenzhen Winkey Technology, P&G Singapore Innovation Center, and Nanyang Technological University, highlights the promise of peptide-drug conjugate (PDC) technology in overcoming longstanding challenges in skincare formulation.

Bridging the Gap Between Peptides and Little Molecules

Traditional skincare often relies on separate active ingredients: peptides to stimulate collagen production and small-molecule antioxidants to neutralize free radicals. While peptides like Hexapeptide-9 (H-9) are effective at signaling the skin to produce collagen, they can be fragile and struggle to penetrate the skin barrier. Conversely, small molecules like caffeic acid (CA) are potent antioxidants but are prone to instability and discoloration.

To address these limitations, researchers covalently linked H-9 and CA to form a single “conjugate” molecule, CH-9. This process ensured a purity level of at least 95% through a convergent solid-phase peptide synthesis strategy [1]. This innovation builds on the established use of PDC technology in pharmaceuticals, where it’s employed to improve drug delivery, but its application in the personal care sector is relatively new.

Superior Protection Against UV Damage

Studies demonstrated that CH-9 offers a remarkable ability to rescue skin cells from the damaging effects of ultraviolet B (UVB) radiation. In laboratory models using human keratinocytes and fibroblasts, CH-9 restored levels of collagen types I, III and IV, whereas H-9 only significantly improved collagen type IV. At higher concentrations, CH-9 promoted the proliferation of skin cells challenged by UV light, highlighting its potential for intensive skin repair and regeneration.

CH-9 displayed a direct antioxidant shield, which H-9 lacked. Using DPPH and ORAC assays, the team proved that CH-9 could successfully scavenge hydroxyl and peroxyl radicals, the primary culprits behind oxidative stress and skin aging [1].

Fighting Inflammation at the Cellular Level

When exposed to UV rays, skin releases pro-inflammatory cytokines like interleukin-6 (IL-6) and interleukin-8 (IL-8), accelerating the aging process – a phenomenon known as “inflammageing.” In 3D full-thickness skin models, treatment with CH-9 significantly reduced the release of these inflammatory markers. In contrast, the parent peptide H-9 showed no significant inhibitory effect. The study suggested that CH-9 suppressed the NF-κB pathway, a master switch for inflammation in human cells.

Deeper Penetration and Formulation Stability

Peptides often struggle to pass through the skin barrier’s oily layers. By attaching the caffeoyl group, researchers modified the molecule’s physical properties to enhance its compatibility with the skin’s surface. Molecular dynamics simulations showed that the caffeoyl moiety allowed the molecule to insert itself more deeply and stably into the stratum corneum. Raman spectroscopy tests on human volunteers confirmed this, revealing significantly higher concentrations of CH-9 in the skin compared to H-9 within 30 minutes of application.

Caffeic acid is prone to oxidation, causing cosmetic serums to discolor. However, the CH-9 conjugate remained clear and stable, suggesting easier formulation in water-based products requiring a long shelf life.

Clinical Results Confirm Firmer Skin

A 28-day double-blind clinical trial involving 96 women aged 40 to 55 demonstrated CH-9’s effectiveness. Participants applied a formulation containing 50μg/mL of either CH-9, H-9, or a placebo twice daily. The CH-9 group saw a 32.17% improvement in gross elasticity and a 30.60% increase in skin firmness, more than double the improvements seen in the H-9 group. Ultrasonic imaging revealed a visible increase in dermal density signals in the skin of those using CH-9.

Looking Ahead

The study suggests that CH-9’s anti-photoageing mechanism is multi-faceted, serving as a proof of concept for using PDC technology to create multifunctional actives. By chemically modifying existing peptides with stable antioxidant groups, cosmetic companies can potentially offer products that penetrate deeper and perform better without the stability issues that plague traditional formulations. As the beauty industry seeks more sophisticated ways to tackle UV damage, hybrid molecules like CH-9 represent a promising shift toward precision-engineered cosmetic chemistry.